Status:
COMPLETED
Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity
Lead Sponsor:
GlaxoSmithKline
Conditions:
Dentinal Hypersensitivity
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of conc...
Detailed Description
This will be a single center, eight week, randomized, controlled, examiner blind, four treatment arms, parallel design study in participants with at least two sensitive teeth that meet all the criteri...
Eligibility Criteria
Inclusion
- Participants between 18 and 55 years of age, in good general health, with pre-existing self-reported and clinically diagnosed tooth sensitivity are required for entry into the study.
- Participants will be required to have at least four teeth with facial/cervical erosion, abrasion and/or gingival recession which respond to qualifying evaporative (air) assessment at the Screening visit and have at least two teeth (incisors, canines or pre-molars) demonstrating signs of sensitivity, measured by qualifying tactile threshold (Yeaple ≤ 20 gram (g)) and evaporative (air) (Schiff Sensitivity Score ≥ 2) assessments at the Baseline visit.
Exclusion
- Specific Dentition Exclusions for Test teeth
- Tooth with evidence of current or recent caries, or reported treatment of decay in 12 months of Screening.
- Tooth with exposed dentin but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing etiologies other than erosion, abrasion or recession of exposed dentin.
- Sensitive tooth not expected to respond to treatment with an over-the-counter dentifrice in the opinion of the investigator
- Use of a sensitivity dentifrice within 8 weeks of screening
- Individuals who require antibiotic prophylaxis for dental procedures
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01831817
Start Date
January 1 2013
End Date
May 1 2013
Last Update
March 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salus Research, Inc.
Fort Wayne, Indiana, United States, 46825